Clinical Trials Browser

Active not recruiting × Clarithromycin × Plasma cell × Clear all

NCT04302324 2025-10-01

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

Phase 2 Active not recruiting

Multiple Myeloma

NCT01559935 2025-09-08

CarBiRD

Phase 2 Active not recruiting

74 enrolled 12 charts

Multiple Myeloma

NCT02542657 2024-09-19

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

Phase 1/2 Active not recruiting

Neoplasms, Plasma Cell